Whirlpool Wins Backing for Import Protection From Key U.S. Panel
Continue Reading Below
Whirlpool won crucial backing from a government panel in its bid to limit competition from foreign washing machine makers, giving the Trump administration another opportunity to invoke little-used powers to ramp up trade enforcement.
YouTube Tweaks Search Results After False Claims Rise to Top
YouTube retooled its search function after top results surfaced videos peddling misinformation, hate and conspiracy on the Las Vegas shooting and NFL anthem protests.
Corona is the New King of Beers
Constellation Brands, the U.S. distributor of Corona and Modelo, reported a 13% jump in beer sales in the summer months
Continue Reading Below
Netflix Raises U.S. Prices for Many New and Current Members
Netflix plans to raise prices for its video-streaming services in a bid to boost its revenue amid rising content costs.
Boeing Deal Targets Flying Taxis
Boeing plans to acquire Aurora Flight Sciences, a maker of aerial drones and pilotless flying systems in a move the company said could pave the way for fleets of pilotless flying taxis.
Uber's Leadership Inches Closer to Stability
Uber's decision to expand its board and give all shareholders equal voting power is bringing the ride-hailing firm's leadership closer to stability after months of scandal and boardroom infighting.
Westinghouse Seeks Up to $8.3 Million in Incentive Bonuses for Top Employees
Westinghouse Electric is seeking permission to award as much as $8.3 million in incentive bonuses to senior management and other high-level employees as it continues to navigate bankruptcy.
TransCanada Ends Two Pipeline Projects
TransCanada said it would end efforts to develop two Canadian energy pipeline projects after facing regulatory delays.
Vivendi's Offices Raided by Police as Media Moguls Wrangle
Police raided the headquarters of French media company Vivendi, controlled by business tycoon Vincent Bolloré, in an investigation into the French firm's purchase of a stake in Italian rival Mediaset.
Appeals Court Rules Against Amgen in Patent Case
A U.S. federal appeals court said Regeneron Pharmaceuticals and partner Sanofi can continue selling their cholesterol drug, dealing a blow to rival Amgen, which had accused the companies of violating its patents.
(END) Dow Jones Newswires
October 05, 2017 15:15 ET (19:15 GMT)